An Integrative Analysis of Transcriptome and Single-Cell RNA Sequencing Data Identifies Key Calmodulin-Related Genes in Osteoarthritis
Genes · 19.11.2026 · 17 (11) · 1470
DOI: 10.3390/genes17111470 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, online erschienen am 19.11.2026. Verfasst von Bingshan Yan und 3 weiteren Autor:innen. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tianjin Health research Project.
Abstract (Originalsprache)
Background/Objectives: Osteoarthritis (OA) is a prevalent degenerative joint disorder lacking disease-modifying therapies, highlighting an urgent need to identify pivotal molecular drivers. Given the crucial role of calcium signaling in chondrocyte biology, this study aimed to systemically identify and characterize key calmodulin-related genes (CaRGs) in OA pathogenesis.
Methods
Transcriptomic data from OA and control synovial tissues (dataset GSE55235) were analyzed to screen for OA-associated CaRGs. Candidate genes were screened using three machine learning algorithms in GSE55235, followed by ROC and expression analyses in GSE55235 and GSE12021 to identify the final key genes. Their functions were explored through enrichment analyses, immune infiltration assessment, and drug prediction. Additionally, the single-cell RNA sequencing dataset GSE216651 was further analyzed to delineate expression patterns, cell-cell communication, differentiation trajectories, and functional states of key cell types. The expression levels of biomarkers were verified by real-time quantitative polymerase chain reaction (RT-qPCR) in OA and tibial plateau fracture surgical controls.
Results
MKNK2 and RYR2 were identified as key genes. MKNK2 was downregulated and linked to suppressed immune pathways, while RYR2 was upregulated and associated with activated immune/lysosomal activity. Immune infiltration analysis revealed significant correlations between these genes and specific immune cells, including neutrophils and type 2 T helper cells. Drug prediction prioritized XMD-12 for MKNK2 and metoprolol for exploratory docking against an RYR2 calmodulin-binding peptide model. Moreover, single-cell analysis localized their high expression to myeloid cells, which in OA exhibited disrupted communication with T/B cells and a skewed early differentiation trajectory. Functional profiling revealed OA myeloid cells were enriched in pathways like Hedgehog signaling and epithelial-mesenchymal transition. In addition, RT-qPCR analysis showed that the expression of RYR2 was significantly upregulated, while the expression of MKNK2 showed the opposite trend in OA, which was consistent with the prediction results of the database.
Conclusions
This study identified MKNK2 and RYR2 as crucial CaRGs in OA. Their distinct expression patterns and strong association with dysregulated myeloid cell function suggest that they may be involved in OA progression through modulation of calcium signaling and immune-stromal crosstalk; however, these mechanistic inferences are derived from computational analyses and require experimental validation. These findings offer potential new diagnostic and therapeutic targets.
Förderung
- Tianjin Health research Project
Zitieren
APA
Yan, B., Zhang, C., Wang, X., & Ning, S. (2026). An Integrative Analysis of Transcriptome and Single-Cell RNA Sequencing Data Identifies Key Calmodulin-Related Genes in Osteoarthritis. Genes, 17(11), 1470. https://doi.org/10.3390/genes17111470
Vancouver
Yan B, Zhang C, Wang X, Ning S. An Integrative Analysis of Transcriptome and Single-Cell RNA Sequencing Data Identifies Key Calmodulin-Related Genes in Osteoarthritis. Genes. 2026;17(11):1470. doi:10.3390/genes17111470
BibTeX
@article{Yan2026,
author = {Yan, Bingshan and Zhang, Chunhong and Wang, Xue and Ning, Shanglong},
title = {An Integrative Analysis of Transcriptome and Single-Cell RNA Sequencing Data Identifies Key Calmodulin-Related Genes in Osteoarthritis},
journal = {Genes},
year = {2026},
volume = {17},
number = {11},
pages = {1470},
doi = {10.3390/genes17111470}
}
EUVIMED